Drugmakers shift from clinical trials, mine EMRs for drug approvals: To gain approval for a new drug or a new use of an existing one, drugmakers are shifting away from conducting traditional clinical trials and instead determining the efficiency of a drug by analyzing data sets from electronic…
To gain approval for a new drug or a new use of an existing one, drugmakers are shifting away from conducting traditional clinical trials and instead determining the efficiency of a drug by analyzing data sets from electronic medical records, according to The Wall Street Journal.
